Matches in SemOpenAlex for { <https://semopenalex.org/work/W2125884080> ?p ?o ?g. }
- W2125884080 abstract "Abstract Background Thromboxane B 2 (TXB 2 ) and superoxide anion (O 2 - ) are neuroinflammatory mediators that appear to be involved in the pathogenesis of several neurodegenerative diseases. Because activated-microglia are the main source of TXB 2 and O 2 - in these disorders, modulation of their synthesis has been hypothesized as a potential therapeutic approach for neuroinflammatory disorders. Marine natural products have become a source of novel agents that modulate eicosanoids and O 2 - generation from activated murine and human leukocytes. With the exception of manzamine C, all other manzamines tested are characterized by a complex pentacyclic diamine linked to C-1 of the β-carboline moiety. These marine-derived alkaloids have been reported to possess a diverse range of bioactivities including anticancer, immunostimulatory, insecticidal, antibacterial, antimalarial and antituberculosis activities. The purpose of this investigation was to conduct a structure-activity relationship study with manzamines (MZ) A, B, C, D, E and F on agonist-stimulated release of TXB 2 and O 2 - from E. coli LPS-activated rat neonatal microglia in vitro . Results The manzamines differentially attenuated PMA (phorbol 12-myristate 13-acetate)-stimulated TXB 2 generation in the following order of decreasing potency: MZA (IC 50 <0.016 μM) >MZD (IC 50 = 0.23 μM) >MZB (IC 50 = 1.6 μM) >MZC (IC 50 = 2.98 μM) >MZE and F (IC 50 >10 μM). In contrast, there was less effect on OPZ (opsonized zymosan)-stimulated TXB 2 generation: MZB (IC 50 = 1.44 μM) >MZA (IC 50 = 3.16 μM) >MZC (IC 50 = 3.34 μM) >MZD, MZE and MZF (IC 50 >10 μM). Similarly, PMA-stimulated O 2 - generation was affected differentially as follows: MZD (apparent IC 50 <0.1 μM) >MZA (IC 50 = 0.1 μM) >MZB (IC 50 = 3.16 μM) >MZC (IC 50 = 3.43 μM) >MZE and MZF (IC 50 >10 μM). In contrast, OPZ-stimulated O 2 - generation was minimally affected: MZB (IC 50 = 4.17 μM) >MZC (IC 50 = 9.3 μM) >MZA, MZD, MZE and MZF (IC 50 > 10 μM). From the structure-activity relationship perspective, contributing factors to the observed differential bioactivity on TXB 2 and O 2 - generation are the solubility or ionic forms of MZA and D as well as changes such as saturation or oxidation of the β carboline or 8-membered amine ring. In contrast, the fused 13-membered macrocyclic and isoquinoline ring system, and any substitutions in these rings would not appear to be factors contributing to bioactivity. Conclusion To our knowledge, this is the first experimental study that demonstrates that MZA, at in vitro concentrations that are non toxic to E. coli LPS-activated rat neonatal microglia, potently modulates PMA-stimulated TXB 2 and O 2 - generation. MZA may thus be a lead candidate for the development of novel therapeutic agents for the modulation of TXB 2 and O 2 - release in neuroinflammatory diseases. Marine natural products provide a novel and rich source of chemical diversity that can contribute to the design and development of new and potentially useful anti-inflammatory agents to treat neurodegenerative diseases." @default.
- W2125884080 created "2016-06-24" @default.
- W2125884080 creator A5004132154 @default.
- W2125884080 creator A5005918512 @default.
- W2125884080 creator A5055000427 @default.
- W2125884080 creator A5065807257 @default.
- W2125884080 creator A5075861802 @default.
- W2125884080 creator A5085033743 @default.
- W2125884080 date "2005-03-11" @default.
- W2125884080 modified "2023-09-27" @default.
- W2125884080 title "Differential modulation of microglia superoxide anion and thromboxane B2 generation by the marine manzamines" @default.
- W2125884080 cites W1563590122 @default.
- W2125884080 cites W1597473130 @default.
- W2125884080 cites W1646206347 @default.
- W2125884080 cites W1676270203 @default.
- W2125884080 cites W1830416824 @default.
- W2125884080 cites W1904406759 @default.
- W2125884080 cites W1945969338 @default.
- W2125884080 cites W1969176034 @default.
- W2125884080 cites W1971223719 @default.
- W2125884080 cites W1974927032 @default.
- W2125884080 cites W1983665859 @default.
- W2125884080 cites W1983845775 @default.
- W2125884080 cites W1985417437 @default.
- W2125884080 cites W1985577234 @default.
- W2125884080 cites W1992268056 @default.
- W2125884080 cites W1997516945 @default.
- W2125884080 cites W2000196140 @default.
- W2125884080 cites W2004298214 @default.
- W2125884080 cites W2008373701 @default.
- W2125884080 cites W2012662246 @default.
- W2125884080 cites W2023736261 @default.
- W2125884080 cites W2028496676 @default.
- W2125884080 cites W2038781543 @default.
- W2125884080 cites W2041086215 @default.
- W2125884080 cites W2041880035 @default.
- W2125884080 cites W2045764828 @default.
- W2125884080 cites W2051256200 @default.
- W2125884080 cites W2054158759 @default.
- W2125884080 cites W2061333828 @default.
- W2125884080 cites W2061974499 @default.
- W2125884080 cites W2066524303 @default.
- W2125884080 cites W2068477037 @default.
- W2125884080 cites W2071251759 @default.
- W2125884080 cites W2071573195 @default.
- W2125884080 cites W2076659607 @default.
- W2125884080 cites W2077261568 @default.
- W2125884080 cites W2077748372 @default.
- W2125884080 cites W2079822311 @default.
- W2125884080 cites W2085590662 @default.
- W2125884080 cites W2087165424 @default.
- W2125884080 cites W2089477527 @default.
- W2125884080 cites W2089701069 @default.
- W2125884080 cites W2097337676 @default.
- W2125884080 cites W2098806111 @default.
- W2125884080 cites W2109728136 @default.
- W2125884080 cites W2109759840 @default.
- W2125884080 cites W2111015407 @default.
- W2125884080 cites W2115637560 @default.
- W2125884080 cites W2134598599 @default.
- W2125884080 cites W2140131793 @default.
- W2125884080 cites W2146957909 @default.
- W2125884080 cites W2147830608 @default.
- W2125884080 cites W2149651502 @default.
- W2125884080 cites W2152344920 @default.
- W2125884080 cites W2159998023 @default.
- W2125884080 cites W2162419586 @default.
- W2125884080 cites W2241643297 @default.
- W2125884080 cites W2246553888 @default.
- W2125884080 cites W2255073174 @default.
- W2125884080 cites W2256891583 @default.
- W2125884080 cites W2284885240 @default.
- W2125884080 cites W2952071811 @default.
- W2125884080 cites W4211087088 @default.
- W2125884080 doi "https://doi.org/10.1186/1471-2210-5-6" @default.
- W2125884080 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1079881" @default.
- W2125884080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15762999" @default.
- W2125884080 hasPublicationYear "2005" @default.
- W2125884080 type Work @default.
- W2125884080 sameAs 2125884080 @default.
- W2125884080 citedByCount "23" @default.
- W2125884080 countsByYear W21258840802012 @default.
- W2125884080 countsByYear W21258840802013 @default.
- W2125884080 countsByYear W21258840802014 @default.
- W2125884080 countsByYear W21258840802015 @default.
- W2125884080 countsByYear W21258840802016 @default.
- W2125884080 countsByYear W21258840802017 @default.
- W2125884080 countsByYear W21258840802021 @default.
- W2125884080 countsByYear W21258840802022 @default.
- W2125884080 crossrefType "journal-article" @default.
- W2125884080 hasAuthorship W2125884080A5004132154 @default.
- W2125884080 hasAuthorship W2125884080A5005918512 @default.
- W2125884080 hasAuthorship W2125884080A5055000427 @default.
- W2125884080 hasAuthorship W2125884080A5065807257 @default.
- W2125884080 hasAuthorship W2125884080A5075861802 @default.
- W2125884080 hasAuthorship W2125884080A5085033743 @default.
- W2125884080 hasBestOaLocation W21258840801 @default.
- W2125884080 hasConcept C170493617 @default.
- W2125884080 hasConcept C181199279 @default.
- W2125884080 hasConcept C185592680 @default.